BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22184093)

  • 1. SOX2 contributes to melanoma cell invasion.
    Girouard SD; Laga AC; Mihm MC; Scolyer RA; Thompson JF; Zhan Q; Widlund HR; Lee CW; Murphy GF
    Lab Invest; 2012 Mar; 92(3):362-70. PubMed ID: 22184093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX2 and nestin expression in human melanoma: an immunohistochemical and experimental study.
    Laga AC; Zhan Q; Weishaupt C; Ma J; Frank MH; Murphy GF
    Exp Dermatol; 2011 Apr; 20(4):339-45. PubMed ID: 21410764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells.
    Santini R; Pietrobono S; Pandolfi S; Montagnani V; D'Amico M; Penachioni JY; Vinci MC; Borgognoni L; Stecca B
    Oncogene; 2014 Sep; 33(38):4697-708. PubMed ID: 24681955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the embryonic stem cell transcription factor SOX2 in human skin: relevance to melanocyte and merkel cell biology.
    Laga AC; Lai CY; Zhan Q; Huang SJ; Velazquez EF; Yang Q; Hsu MY; Murphy GF
    Am J Pathol; 2010 Feb; 176(2):903-13. PubMed ID: 20042675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma.
    Ravindran Menon D; Luo Y; Arcaroli JJ; Liu S; KrishnanKutty LN; Osborne DG; Li Y; Samson JM; Bagby S; Tan AC; Robinson WA; Messersmith WA; Fujita M
    Cancer Res; 2018 Dec; 78(23):6561-6574. PubMed ID: 30297536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells.
    Ma K; Pan X; Fan P; He Y; Gu J; Wang W; Zhang T; Li Z; Luo X
    Mol Cancer; 2014 May; 13():118. PubMed ID: 24885288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells.
    Weina K; Wu H; Knappe N; Orouji E; Novak D; Bernhardt M; Hüser L; Larribère L; Umansky V; Gebhardt C; Utikal J
    Pigment Cell Melanoma Res; 2016 Jul; 29(4):453-8. PubMed ID: 27105574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX2 Promotes Invasion in Human Bladder Cancers through MMP2 Upregulation and FOXO1 Downregulation.
    Xie Q; Hua X; Huang C; Liao X; Tian Z; Xu J; Zhao Y; Jiang G; Huang H; Huang C
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells.
    Oppel F; Müller N; Schackert G; Hendruschk S; Martin D; Geiger KD; Temme A
    Mol Cancer; 2011 Nov; 10():137. PubMed ID: 22070920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway.
    Yang N; Hui L; Wang Y; Yang H; Jiang X
    Oncol Rep; 2014 Jun; 31(6):2651-9. PubMed ID: 24700142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix softness regulates plasticity of tumour-repopulating cells via H3K9 demethylation and Sox2 expression.
    Tan Y; Tajik A; Chen J; Jia Q; Chowdhury F; Wang L; Chen J; Zhang S; Hong Y; Yi H; Wu DC; Zhang Y; Wei F; Poh YC; Seong J; Singh R; Lin LJ; Doğanay S; Li Y; Jia H; Ha T; Wang Y; Huang B; Wang N
    Nat Commun; 2014 Aug; 5():4619. PubMed ID: 25099074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway.
    Thyagarajan A; Saylae J; Sahu RP
    Oncotarget; 2017 Jul; 8(30):49959-49972. PubMed ID: 28636992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLI2-mediated melanoma invasion and metastasis.
    Alexaki VI; Javelaud D; Van Kempen LC; Mohammad KS; Dennler S; Luciani F; Hoek KS; Juàrez P; Goydos JS; Fournier PJ; Sibon C; Bertolotto C; Verrecchia F; Saule S; Delmas V; Ballotti R; Larue L; Saiag P; Guise TA; Mauviel A
    J Natl Cancer Inst; 2010 Aug; 102(15):1148-59. PubMed ID: 20660365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfection of T-Box Transcription Factor
    Akimoto N; Nakamura K; Hijioka H; Kume K; Matsumura Y; Sugiura T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo.
    Cesarini V; Guida E; Todaro F; Di Agostino S; Tassinari V; Nicolis S; Favaro R; Caporali S; Lacal PM; Botti E; Costanzo A; Rossi P; Jannini EA; Dolci S
    Oncogene; 2017 Aug; 36(31):4508-4515. PubMed ID: 28368402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen.
    Benbow U; Schoenermark MP; Mitchell TI; Rutter JL; Shimokawa K; Nagase H; Brinckerhoff CE
    J Biol Chem; 1999 Sep; 274(36):25371-8. PubMed ID: 10464264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines.
    Mercapide J; Lopez De Cicco R; Castresana JS; Klein-Szanto AJ
    Int J Cancer; 2003 Sep; 106(5):676-82. PubMed ID: 12866026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion.
    Khosravi S; Tam KJ; Ardekani GS; Martinka M; McElwee KJ; Ong CJ
    J Invest Dermatol; 2015 May; 135(5):1358-1367. PubMed ID: 25562667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.